PETMED EXPRESS INC (PETS) PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.
Sector: Retail-Drug Stores and Proprietary Stores
Industry: Specialty Retail
PetMed Express, Inc. NASDAQ:PETS Consumer Cyclical · Specialty Retail
Mkt Cap $27.09M
Earnings Dec 18 · in 6w
Prev close $1.24 Close $1.22 0.00% AH close $1.22
Mkt Cap $27.09M
Earnings Dec 18 · in 6w
Press Release
PetMed Express, Inc. to Report Second Quarter Fiscal Year 2027 Financial Results on Tuesday, November 10, 2026
PetMed Express (PETS) will report second quarter fiscal 2027 results for the period ended September 30, 2026 on Tuesday, November 10, 2026 after market close.
A conference call and webcast to review the results will be held at 4:30pm Eastern Time the same day, with a telephonic replay available through November 24, 2026.
This is a scheduling notice only; no financial results are included.
• 12d ago AI analysis › Press Release ● Major
PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com • 1mo ago Press Release ● Major
PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
globenewswire.com • 1mo ago Press Release
PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition
globenewswire.com • 1mo ago Press Release
PetMeds Appoints Andrew Parry as Chief Technology Officer
globenewswire.com • 1mo ago Press Release ● Major
PetMeds® Announces First Quarter Financial Results
globenewswire.com • 2mo ago Press Release
PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026
PetMed Express (PETS) announced it will report its first quarter fiscal year 2027 financial results on Thursday, August 13, 2026, after the market close.
The company will host a conference call and webcast at 4:30pm Eastern Time to review the results.
PetMeds operates as a direct-to-consumer pet pharmacy licensed across all 50 states, offering pharmaceuticals and wellness products through its family of brands.
• 3mo ago AI analysis › Press Release ● Critical
PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million
globenewswire.com • 3mo ago Press Release ● Critical
PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform
globenewswire.com • 3mo ago Press Release ● Major ⚠ 2
PetMed Express, Inc. Confirms Receipt of Unsolicited, Non-Binding, and Conditional Acquisition Proposal from SilverCape Investments Limited
PetMed Express confirmed receipt of a new unsolicited, non-binding proposal from SilverCape Investments to acquire all outstanding shares for $3.00 per share in cash.
This new offer is significantly lower than SilverCape's prior proposal of $4.00 per share made in December 2025, following the bidder's refusal earlier this year to sign a customary nondisclosure and standstill agreement.
The Board stated it will evaluate the proposal only if SilverCape executes the required agreement, emphasizing that no determination has been made and there is no assurance a transaction will occur.
• 4mo ago AI analysis › Press Release ● Major ⚠ 4
SilverCape Releases Revised Proposal to Acquire PetMed Express for $3.00 per Share in Cash
SilverCape Investments, a 12% shareholder, released a revised proposal to acquire PetMed Express for $3.00 per share in cash, a 70% premium to the June 26 closing price of $1.76.
The activist investor lowered its offer from a prior $4.00 per share proposal, citing the company's deteriorating financial condition which has seen cash balances drop from $54.7 million to $21.4 million.
SilverCape criticized the board for rejecting previous bids and failing to run a bona fide sale process, highlighting recent 'going concern' doubts and governance issues under interim CEO Leslie C.G. Campbell.
• 4mo ago AI analysis › Press Release ● Major
PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results
globenewswire.com • 5mo ago Press Release
PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026
PetMed Express, Inc. (PETS) announced it will report fourth quarter and fiscal year 2026 financial results on Tuesday, June 2, 2026, after market close.
The company will host a conference call and webcast at 4:30 pm Eastern Time to discuss the results.
No financial figures or guidance were included in this date-setting notice.
• 5mo ago AI analysis › Press Release ● Critical
PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels
globenewswire.com • 6mo ago 
